Post-partum contraception in women living with HIV

HIV Med. 2023 Mar;24(3):354-360. doi: 10.1111/hiv.13371. Epub 2022 Aug 16.

Abstract

Introduction: Rates of unintended pregnancy are higher in women living with HIV than in those without HIV. The World Health Organization and the Canadian HIV Pregnancy Planning Guidelines recommend preventing unintended pregnancies and offering contraception counselling to women living with HIV to reduce the rate of perinatal HIV transmission worldwide. No studies have assessed post-partum (PP) contraception use in women living with HIV in Canada.

Methods: We conducted a retrospective chart review including all women living with HIV followed by the Oak Tree Clinic who had a live birth between 1 January 2014 and 15 September 2019. The main objective was to quantify the proportion and types of contraception used by women living with HIV within 3 months PP and to evaluate whether contraception counselling is associated with contraception use.

Results: Of the 110 participants included, 79% were using contraception within 3 months PP. The most common contraception methods used were an intrauterine device in 22% of participants followed by depot-medroxyprogesterone acetate in 18% of participants. Of those intending to use contraception PP, 86% and 92% were using contraception within 3 and 12 months PP, respectively. Contraception counselling during pregnancy, and up to 3 months PP, was associated with contraception use within 3 months PP (p < 0.05).

Conclusion: The majority of women were using contraception within 3 months PP. Having a contraception plan resulted in a high rate of contraception use. Women living with HIV should have a PP contraception plan prior to giving birth to establish the necessary steps for starting highly reliable forms of contraception. Contraception counselling was associated with contraception use and should be incorporated during pregnancy and in the immediate PP period.

Keywords: HIV; contraception; contraception counselling; post-partum; pregnancy.

MeSH terms

  • Canada
  • Contraception / methods
  • Female
  • HIV Infections*
  • Humans
  • Postpartum Period
  • Pregnancy
  • Retrospective Studies